Omnicell

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Omnicell and other ETFs, options, and stocks.

About OMCL

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation.

CEO

Randall A. Lipps

CEORandall A. Lipps

Employees

3,580

Employees3,580

Headquarters

Fort Worth, Texas

HeadquartersFort Worth, Texas

Founded

1992

Founded1992

Employees

3,580

Employees3,580

OMCL Key Statistics

Market cap

1.92B

Market cap1.92B

Price-Earnings ratio

937.47

Price-Earnings ratio937.47

Dividend yield

—

Dividend yield—

Average volume

625.83K

Average volume625.83K

High today

$42.43

High today$42.43

Low today

$40.64

Low today$40.64

Open price

$40.88

Open price$40.88

Volume

769.22K

Volume769.22K

52 Week high

$55.00

52 Week high$55.00

52 Week low

$22.66

52 Week low$22.66

Stock Snapshot

With a market cap of 1.92B, Omnicell(OMCL) trades at $42.25. The stock has a price-to-earnings ratio of 937.47.

During the trading session on 2026-03-05, Omnicell(OMCL) shares reached a daily high of $42.43 and a low of $40.64. At a current price of $42.25, the stock is +4.0% higher than the low and still -0.4% under the high.

Trading volume for Omnicell(OMCL) stock has reached 769.22K, versus its average volume of 625.83K.

Over the past 52 weeks, Omnicell(OMCL) stock has traded between a high of $55.00 and a low of $22.66.

OMCL News

Simply Wall St 21h

Omnicell Leans Into Healthcare IT As ANiGENT Deal Reshapes Growth Story

Omnicell, ticker NasdaqGS:OMCL, is shifting its focus toward a software and services led model. The company recently acquired ANiGENT to deepen its capabilitie...

Simply Wall St 4d

Assessing Omnicell Valuation As ANiGENT Deal Accelerates Shift To Software And Services

Omnicell (OMCL) is drawing fresh investor attention after its shift toward software and services was underscored by the ANiGENT acquisition, a move that centers...

Simply Wall St 5d

Should Omnicell’s Shift Toward Software and Services Require Action From Omnicell Investors?

Omnicell has recently accelerated its shift from hardware-focused sales toward software and services, including acquiring ANiGENT in October 2025 to broaden its...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own OMCL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.